Pernod Ricard (RI) Investor update (Q&A) summary
Event summary combining transcript, slides, and related documents.
Investor update (Q&A) summary
28 May, 2026Route to market and distribution changes
Transitioned 11 states, including Texas, to new wholesalers, focusing on a 'fittest athlete by state' approach for optimal partnerships.
Texas and four other major states now consolidated under Southern, enabling more streamlined operations and collaboration.
Transition to Reyes for RTD distribution in seven markets, leveraging their beer distribution expertise.
Financial and operational disruption from these changes has been minimal, with fill rates above 80% and seamless integration.
New relationships with distributors for 'gem' brands to allow focused incubation and growth.
Brand and portfolio strategy
Focus on Power Six brands, with over 70% of A&P resources allocated to them for maximum impact.
Innovations like Malibu Pink and Malibu-Dole collaboration are driving momentum, especially for summer occasions.
Skrewball addressed initial supply and promotional challenges, now seeing improved performance with new small-size formats.
Jameson strategy includes targeted recruitment, new pack sizes, and premium innovations to capture under-indexed segments.
Martell and Chivas follow a 'Targeted Elevate' strategy in select states, while Seagram's is managed for commercial execution only.
Pricing, profitability, and resource allocation
Pricing environment is closely monitored weekly, with a focus on data-driven, state-specific decisions.
A&P spend is held at 18% of net sales, with improved efficiency and concentration on fewer brands.
AI-driven Matrix tool guides over 70% of marketing investment decisions, optimizing ROI.
SG&A and organizational structure are regularly reviewed for agility and cost discipline.
Smaller pack sizes, including 100ml cans, are profitable and supply chain is agile to support growth.
Latest events from Pernod Ricard
- Key brands outperform competitors as innovation and execution drive improved momentum.RI
Investor update28 May 2026 - Q3 organic net sales rose 4.1%, but full-year sales are forecast to decline 3–4% amid FX headwinds.RI
Q3 202616 Apr 2026 - Sales and profit declined, but free cash flow and efficiency gains support a positive outlook.RI
H1 20268 Apr 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 20263 Feb 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 202423 Jan 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Stable sales, margin gains, and a €4.70 dividend headline a governance-focused AGM.RI
AGM 202415 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Resilient results, stable dividends, and all resolutions approved amid global challenges.RI
AGM 202527 Dec 2025